Group One Trading
SURF

Group One Trading’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Group One Trading’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,500
Closed -$1.3K – 8583
2023
Q2 		$1.3K Buy
+1,500
New +$1.07K ﹤0.01% 7207
2023
Q1 		– Sell
-27,100
Closed -$22.2K – 8200
2022
Q4 		$22.2K Sell
27,100
-26,800
-50% -$26.4K ﹤0.01% 5532
2022
Q3 		$56K Sell
53,900
-15,400
-22% -$24.6K ﹤0.01% 5318
2022
Q2 		$114K Buy
69,300
+7,500
+12% +$15.6K ﹤0.01% 4864
2022
Q1 		$182K Buy
61,800
+14,800
+31% +$51.9K ﹤0.01% 4896
2021
Q4 		$225K Sell
47,000
-30,100
-39% -$194K ﹤0.01% 4965
2021
Q3 		$584K Buy
77,100
+20,900
+37% +$134K ﹤0.01% 4017
2021
Q2 		$419K Sell
56,200
-107,100
-66% -$825K ﹤0.01% 4417
2021
Q1 		$1.27M Buy
163,300
+151,300
+1,261% +$1.51M ﹤0.01% 2950
2020
Q4 		$111K Buy
+12,000
New +$104K ﹤0.01% 4492

Group One Trading's SURF Position: Q3 2023 in Review

Group One Trading sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 6,774 shares — an estimated $5.89K sold.

Group One Trading first reported a position in SURF in Q4 2020 and held it in 7 quarters. The position peaked at $125K in Q4 2020. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

  • Group One Trading reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 6,774 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $5.89K.
  • Group One Trading first reported a position in Surface Oncology, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
  • Group One Trading's Surface Oncology, Inc. Common Stock position peaked at $125K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.